Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31264274 | 1.00 | CYP1A2 (0.55) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL69653 | 0.86 | MAPT (0.64) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL8571638 | 0.82 | CYP1A2 (0.44) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL13018321 | 0.82 | CYP1A2 (0.44) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL9426972 | 0.81 | CYP1A2 (0.59) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL28179233 | 0.81 | TSHR (0.44) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL30077004 | 0.80 | CYP1A2 (0.43) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL32668996 | 0.80 | ALDH1A1 (0.61) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL31337797 | 0.80 | CYP1A2 (0.77) | CYP1A2SMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL12468872 | 0.80 | CYP1A2 (0.43) | CYP1A2SMN1; SMN2NPC1RAB9ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257050-A1 | PROCESS FOR THE PREPARATION OF VORASIDENIB | SERVIER PHARMACEUTICALS LLC | 2025-08-14 | — | — | US | claimed |
| CN-119592966-A | Method for synthesizing ester compounds by high-selectivity dechlorination electro-catalysis | 浙江工业大学 | 2025-03-11 | — | — | CN | claimed |
| CN-111151248-A | Method for catalyzing heterocyclic halogen-containing organic matter hydrogenation dehalogenation by using supported metal oxide | 浙江大学 | 2020-05-15 | — | — | CN | claimed |
| EP-3704101-B1 | COCRYSTALS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF TREATMENT INVOLVING SAME | SERVIER LAB (FR) | 2026-05-06 | — | — | EP | disclosed |
| US-20260055108-A1 | TRIAZINE COMPOUNDS AND USES THEREOF | HUTCHMED LTD (CN) | 2026-02-26 | — | — | US | disclosed |
| US-12528815-B2 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer | NXERA PHARMA UK LIMITED (GB) | 2026-01-20 | — | — | US | disclosed |
| EP-4676918-A1 | COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS | Nanjing Immunophage Biomedical Co., Ltd. (CN) | 2026-01-14 | — | — | EP | disclosed |
| EP-4647076-A2 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | Les Laboratoires Servier (FR) | 2025-11-12 | — | — | EP | disclosed |
| US-12433895-B2 | Therapeutically active compounds and their methods of use | SERVIER PHARMACEUTICALS LLC (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250304603-A1 | OXABOROLE ESTERS AND USES THEREOF | ANACOR PHARMACEUTICALS INC (US) | 2025-10-02 | — | — | US | disclosed |
| EP-4620533-A2 | ANTAGONIST COMPOUNDS | Adorx therapeutics Limited (GB) | 2025-09-24 | — | — | EP | disclosed |
| EP-0488474-A1 | Herbicidal carboxamide derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-06-03 | — | — | EP | disclosed |
| WO-1991015476-A1 | SUBSTITUTED CYCLOHEXANEDIONES AND THEIR HERBICIDAL USES | DOWELANCO (US) | 1991-10-17 | — | — | WO | disclosed |
| EP-0450712-A2 | Substituted cyclohexanediones and their herbicidal uses | DOWELANCO (US) | 1991-10-09 | — | — | EP | disclosed |
| EP-0447004-A2 | Herbicidal carboxamide derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-09-18 | — | — | EP | disclosed |
| US-5013352-A | Grassy weeds in presence of crops | DOWELANCO (US) | 1991-05-07 | — | — | US | disclosed |
| US-5010201-A | Process for the preparation of substituted 2-chloropyridines | BAYER AKTIENGESELLSCHAFT (DE) | 1991-04-23 | — | — | US | disclosed |
| US-4499275-A | PESTICIDES; INSECTICIDES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1985-02-12 | — | — | US | disclosed |
| US-4393213-A | Process for producing 6-phenoxypicolinic aldehydes | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1983-07-12 | — | — | US | disclosed |
| US-4251662-A | INSECTICIDES, MITICIDES | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1981-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433895-B2 | Therapeutically active compounds and their methods of use | MCL1, TP53, BRDT | CYP1A2 4636/4885SMN1; SMN2 568/4885NPC1 513/4885 |
| US-20250304603-A1 | OXABOROLE ESTERS AND USES THEREOF | OXA1L, HSD17B12, OXER1 | CYP1A2 247/4885SMN1; SMN2 442/4885NPC1 1483/4885 |
| US-20250257050-A1 | PROCESS FOR THE PREPARATION OF VORASIDENIB | SAMHD1, DPYD, MVD | CYP1A2 492/4885SMN1; SMN2 1870/4885NPC1 1258/4885 |
| US-20260055108-A1 | TRIAZINE COMPOUNDS AND USES THEREOF | CBR1, CNR1, CBR3 | CYP1A2 134/4885SMN1; SMN2 3344/4885NPC1 130/4885 |
| US-12528815-B2 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer | ADORA1, ADORA3, OPRL1 | CYP1A2 1308/4885SMN1; SMN2 1824/4885NPC1 488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.